FDAFDA · Food and drugs·Recall number D-0443-2024
Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10
Published April 24, 2024 · Recall initiated: March 25, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DIGOXIN
- Manufacturer
- Novitium Pharma LLC
- Distributor
- U.S. Nationwide
- UPC
- 0370954201106
- Lot
- Lot M23011A; Exp. 12/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.